BERKELEY, Calif., March 18, 2025 (GLOBE NEWSWIRE) — Kimia Therapeutics, Inc. (Kimia), a biotechnology company generating a chemical atlas for treating human disease, today announced the appointment of Imran S. Haque, Ph.D., to the role of chief technology officer. Dr. Haque, who was most recently senior vice president of AI and digital sciences at Recursion, […]
Kimia Therapeutics appointed Imran S. Haque, Ph.D., as Chief Technology Officer. He will lead development of the ATLAS technology platform, bringing nearly 20 years of experience in chemistry, biology, and machine learning.